Nestle Health Science US Holdings, Inc.'s Net Worth
-$152 Million
Who is Nestle Health Science US Holdings, Inc.?
Nestle Health Science US Holdings, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., Axcella Health Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Nestle Health Science US Holdings, Inc.'s CIK is 0001644164
Past Insider Trading and Trends
2015 was Nestle Health Science US Holdings, Inc.'s most active year for acquiring shares with 2 total transactions. Nestle Health Science US Holdings, Inc.'s most active month to acquire stocks was the month of January. 2015 was Nestle Health Science US Holdings, Inc.'s most active year for disposing of shares, totalling 1 transactions. Nestle Health Science US Holdings, Inc.'s most active month to dispose stocks was the month of May. 2018 saw Nestle Health Science US Holdings, Inc. paying a total of $128,000,002.83 for 4,175,029 shares, this is the most they've acquired in one year. In 2015 Nestle Health Science US Holdings, Inc. cashed out on 3,611,111 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.00% | 1.33M |
$18.00 | $23,999,994.00 | 6.89M |
Jul 1
| |||
Form 4
| +185.71% | 3.61M |
—
|
—
| 5.56M |
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) Snapshot price: $0.4009
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +81.77% | 1.94M |
$4.75 | $9,199,999.50 | 4.31M |
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aimmune Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +55.28% | 4.18M |
$30.66 | $128,000,002.83 | 11.73M |
Feb 26 - Nov 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||